Fri, February 7, 2025
[ Fri, Feb 07th 2025 ]: Investopedia
Calculating Risk and Reward
Thu, February 6, 2025
[ Thu, Feb 06th 2025 ]: AOL
How to invest in the music industry
[ Thu, Feb 06th 2025 ]: MSN
An ETF for Every Age: 18 to 35

Eli Lilly Stock Rises After Profit, Outlook Top Expectations

Eli Lilly and Co. experienced a significant boost in its stock price after the company announced a profit outlook for 2023 that exceeded Wall Street's expectations. The pharmaceutical giant projected earnings per share to be between $8.35 and $8.55, surpassing the consensus estimate of $7.74. This optimistic forecast was driven by strong demand for their diabetes drug Mounjaro, which has shown potential in weight loss treatments, and other key products like Verzenio for breast cancer and Taltz for psoriasis. Additionally, Eli Lilly raised its full-year revenue guidance to a range of $30.3 billion to $30.8 billion, up from a previous estimate of $28.5 billion to $29.5 billion. The company also reported better-than-expected Q2 results, with earnings and revenue both beating forecasts, further fueling investor confidence.

Read the Full Kiplinger Article at:
[ https://www.kiplinger.com/investing/stocks/eli-lilly-stock-rises-after-profit-outlook-top-expectations ]